Home / Inspections / 1244033

FDA Inspection 1244033 — GlaxoSmithKline Manufacturing S.p.A.

GlaxoSmithKline Manufacturing S.p.A. — FEI 3002807114

The FDA completed an inspection of GlaxoSmithKline Manufacturing S.p.A. on October 26, 2023 in Torrile. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
October 26, 2023
Fiscal Year
2024
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Torrile (Italy)

Additional Details

Mutual Recognition Agreement (MRA)

Facility

Other inspections at this facility

  • 1064045 (VAI Fri Sep 29 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 982333 (NAI Fri Jul 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 934049 (VAI Wed May 27 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 842545 (NAI Wed Jul 10 2013 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 801922 (NAI Fri Sep 21 2012 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources